Difference between revisions of "Danaparoid (Orgaran)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (→Also known as) |
Warner-admin (talk | contribs) m (Text replacement - "Category:Venous thromboembolism (VTE) medications" to "Category:Venous thromboembolism medications") |
||
| Line 16: | Line 16: | ||
[[Category:Heparin-induced thrombocytopenia medications]] | [[Category:Heparin-induced thrombocytopenia medications]] | ||
| − | [[Category:Venous thromboembolism | + | [[Category:Venous thromboembolism medications]] |
[[Category:FDA approved in 2001]] | [[Category:FDA approved in 2001]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Revision as of 19:45, 27 February 2019
General information
Class/mechanism: Low molecular weight heparin
History of changes in FDA indication
- 6/26/2001: Initial FDA approval
Also known as
- Brand name: Orgaran